The New Jersey Alliance for
Clinical and Translational Science
Announcements, Deadlines, Reminders
March 30, 2021
|
|
NJ ACTS Biostatistics and Epidemiology
Workshop Series
Thursday, April 1, 2021
|
|
“Adaptive Designs in Clinical Trials: An Introduction and Examples”
Professor
Department of Biostatistics and Epidemiology
When: Thursday, April 1, 2021
2:30pm – 4:00pm
Target Audience: Faculty/Staff/Trainees/Students wanting to know more about
specific, advanced RCT study designs
*ALL RESEARCH EXPERIENCE LEVELS WELCOME*
After registering, you will receive a confirmation email containing information about joining the workshop.
|
|
Rutgers and Tel Aviv Universities Joint Research Symposia
Advances in Gene Therapy
Tuesday, April 6, 2021
|
|
Join leading experts from Rutgers and Tel Aviv Universities for the upcoming research symposium examining advances in gene therapy.
FEATURED SPEAKERS
M. Maral Mouradian, MD
William Dow Lovett Professor of Neurology, Robert Wood Johnson Medical School (RWJMS); Founding Director of RWJMS Institute for Neurological Therapeutics; Vice Chancellor for Faculty Development, Rutgers Biomedical and Health Sciences, Rutgers University
Karen Avraham, PhD
Professor, Department of Human Molecular Genetics & Biochemistry, Vice Dean for Preclinical Affairs, Sackler Faculty of Medicine, Tel Aviv University
Presentations will be followed by a moderated Q&A session.
|
|
RITMS Visiting Professor Lecture Series
Thursday April 8, 2021
|
|
“Mechanisms for HIV-associated cardiovascular disease”
Presented by:
Tricia Burdo, PhD
Associate Professor
Neuroscience Lewis Katz School of Medicine at Temple University
12:00pm – 1:00pm
April 8th, 2021
|
|
NIH's All of Us Research Program:
Promoting Team Science at the National Level
Monday, April 12, 2021
|
|
The All of Us Research Program, begun in 2015, is a nation-wide Precision Medicine Initiative by the Institutes of Health. By gathering data from at least 1 million volunteers through EMR data, smart phones and wearable sensors, the goal is to learn how to better tailor treatments and preventive care to people’s genes, environment and lifestyle.
This seminar, offered as part of the NJ ACTS Team Science Course, will highlight this program as a model of team science. It serves as an illustration of the power of multi-disciplinary broad-based team to achieve programmatic goals.
The seminar will be presented by:
- Courtney Wallin, Researcher Engagement, Lead, All of Us Research Program
- Kelsey Mayo, PhD, Data & Research Center, All of Us Research Program
April 12, 2021
3: 00 pm-4:00 pm
|
|
NJ ACTS Team Science Core
Team Science Seminar Series
Inaugural Event
Monday April 19, 2021
|
|
Patrick Hobbs
Director of Intercollegiate Athletics
Rutgers, The State University & RU Athletic Coaches
“Secrets of Successful Teamwork:
What Can Academia Learn from Non-Academia?”
Monday, April 19, 2021
2:30 – 3:30 PM
Register in advance for this zoom meeting:
|
|
Workforce Development Core
Clinical and Translational Science Intern Symposium
Tuesday, April 20, 2021
|
|
The NJ ACTS Workforce Development Core at Rutgers University is inviting you to the
Spring Virtual Student Internship Final Symposium.
After working intensely with members of the NJ ACTS core leads, they have networked with trainees/clinicians/scientists, learned about NJ ACTs, and now they are all excited to share their experiences, and provide insight into their final project deliverables.
Tuesday, April 20, 2021
6:00 pm
|
|
OnCore Clinical Trial Management System
Enterprise-wide Roll-out
As part of the overall mission to improve the efficiency and quality of the clinical trials conducted at RBHS, we are expanding the use of OnCore, a clinical trials management system (CTMS), from CINJ to all of RBHS. This is made possible by a significant investment of resources from RBHS and NJ ACTS.
OnCore is a web-based software system designed to help institutions manage their clinical trial portfolio. The enterprise-wide implementation has extended OnCore’s functionality and impact through multiple enhancements, including interfaces with eIRB (already live), the electronic medical record systems, and eventually receivables and billing.
OnCore will enable us to improve the efficiency of study start-up procedures, such as budgeting and contracting, as well as to standardize and improve clinical research workflows in general. Participant visits and completion of study procedures are recorded in OnCore, and OnCore’s e-Regulatory system enables the creation of electronic regulatory binders.
OnCore is being rolled out in a phased approach for Non-Oncology research at RBHS. The first phase began in February 2021 and includes the NJMS Clinical Research Unit and the NJMS Infectious Disease clinical research group. The second phase will involve extension of the system to the RWJMS Clinical Research Centers, followed by additional clinical research groups on both campuses.
If you are a CINJ researcher and need more information on OnCore, please contact Yifang Zhou at zhouyi1@cinj.rutgers.edu.
|
|
BERD Mini-Methods Grant Program
Applications Accepted at Any Time
|
|
The Mini-Methods-Grant program offers one-year awards of up to $25,000 to investigators developing methodology in study design, measurement, statistical analysis, and approaches to the integration of quantitative and qualitative data analysis relevant to translational research.
BERD seeks proposals that:
(1) Develop innovative measurement and/or analytic methods that identify disparate patterns of disease or identify factors that might be key in leading to differential responses to therapy
(2) Solve health challenges encountered by existing translational research projects within NJACTS
(3) Demonstrate the potential for future independent funding.
BERD especially encourage proposals that: (1) relate to studies being undertaken by TL1/KL2 trainees with methodological challenges; and/or (2) include researchers from two or more of the participating institutions (Rutgers, Princeton, and NJIT).
Proposals are accepted on a rolling basis.
|
|
NJ ACTS Workforce Development Core
Spring 2021
Mentor Seminar Series
April 20th
|
|
Mentor Networking Series: Aligning Expectations
Tuesday, April 20, 2021
12-1 pm
Join the follow up Mentoring Networking Series on Aligning Expectations to connect with fellow faculty mentors and have discussions about aligning expectations through case studies.
Presenters:
Andrew Gow, PhD, Professor, Ernest Mario School of Pharmacy
Anita Siu, Pharm.D., BCPPS, Clinical Professor, Ernest Mario School of Pharmacy
|
|
NJ ACTS Workforce Development Core
Spring 2021
Professional Training Session
April 5, 2021
|
|
Interested in expanding your knowledge of clinical and translational science? Come join us for a training series geared to the advancement of clinical and translational research within a diverse workforce.
Communicating Your Translational Science
Monday, April 5, 2021
12:00 pm
|
|
NJ ACTS Special Populations
2021 Webinar Series
April 16th and May 11th
|
|
Friday, April 16, 2021
12:00 pm - 1:00 pm
Cannabis Use and Perceived Risk of Use Among Pregnant Women in the U.S.
Presented By:
Qiana L. Brown, PhD, MPH, LCSW
Prenatal cannabis use has increased over the past decade, despite potential risks to maternal and child health. This seminar examines the relationship between cannabis use and perceived risk of cannabis use among pregnant women in the US.
|
|
Tuesday, May 11, 2021
12:00 pm - 1:00 pm
Medications for Opioid Use Disorder and Peer Health Navigation for Persons Leaving NJ State Prisons and Returning to the Community – Early Findings
Presented By:
Donald (Rusty) Reeves, MD
Peter Treitler, MSW
Risk of relapse and adverse health events is high following prison release, with risk of fatal overdose 129 times greater in the 2 weeks post-release than in the general population. During this seminar, the presenters will discuss early findings from their mixed-methods studies on the implementation and outcomes of two novel interventions to reduce harm: pre-release medication for opioid use disorder and the Intensive Recovery Treatment Support (IRTS) peer health navigator program.
Zoom Link and Flyer Coming Soon!
|
|
Introducing the New Jersey
Practice-Based Research Network
June 3-4, 2021
|
|
The New Jersey Practice-Based Research Network is a new initiative to increase the presence of New Jersey clinical practices in academic research. Join us to mark the launch of the network, bringing together clinicians, researchers, and leaders across the country.
DAY 1: 10 am - 1 pm ET Thursday, June 3, 2021
Welcome:
XinQi Dong, MD, MPH, Director, Rutgers Institute for Health, Health Care Policy and Aging Research & Henry Rutgers Distinguished Professor of Population Health Sciences
Keynotes:
• Shereef Elnahal, MD, MBA, President & CEO, University Hospital Newark & former commissioner, New Jersey Department of Health
• Andy Anderson, MD, President & CEO, RWJBH Medical Group
DAY 2: 10 am - 1 pm ET Friday, June 4, 2021
Welcome:
• Ann M. Nguyen, PhD, MPH, Director, NJPBRN
• Rey A. Panettieri, Jr, MD, Director, Rutgers Institute for Translational Medicine and Science & Vice Chancellor for Translational Medicine and Science, Rutgers University
Keynotes:
• Lawrence Casalino, MD, MPH, PhD, Professor of Population Health Sciences, Weill Cornell Medical College
• Alonzo L. Plough, PhD, MA, MPH, VP, Research-Evaluation-Learning & Chief Science Officer, Robert Wood Johnson Foundation
VIRTUAL EVENT | CME CREDITS AVAILABLE
|
|
NCATS National COVID Cohort Collaborative (N3C)
|
|
Data Enclave Updates!
NCATS National COVID Cohort Collaborative (N3C) Data Enclave is a centralized and secure data platform, featuring powerful analytics capabilities for online discovery, visualization and collaboration. The data are robust in scale and scope and are transformed into a harmonized data set to help academic researchers, clinicians, and citizen scientists study COVID 19.
|
|
Kelly C. Young-Wolff; Lynn D. Silver; Qiana L. Brown. JAMA Network Open, February 25, 2021.
Lisa Cooper, Irene Lee, Doreen Waldron Lechner. Published online by Cambridge University Press: 16 March 2021, pp. 1-20
|
|
NJ ACTS is a partnership between Rutgers, NJIT and Princeton, NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health.
|
|
This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number, UL1TR003017 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.
New Jersey Alliance for Clinical and Translational Science
89 French St., Suite 4211
New Brunswick, NJ
Copyright 2020 New Jersey Alliance for Clinical and Translational Science, all rights reserved
UL1TR003017, KL2TR003018 and TL1TR003019
|
|
|
|
|
|
|
|
|
|
